{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T12:48:45Z","timestamp":1791982125611,"version":"4.4.0"},"reference-count":42,"publisher":"Impact Journals, LLC","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncotarget"],"published-print":{"date-parts":[[2020,1,14]]},"DOI":"10.18632\/oncotarget.27415","type":"journal-article","created":{"date-parts":[[2020,1,14]],"date-time":"2020-01-14T13:58:46Z","timestamp":1579010326000},"page":"148-160","source":"Crossref","is-referenced-by-count":5,"title":["Isolation and characterization of a CD34+ sub-clone in B-cell lymphoma"],"prefix":"10.18632","volume":"11","author":[{"given":"Ayad M.","family":"Al-Katib","sequence":"first","affiliation":[{"name":"Lymphoma Research Laboratory, Department of Internal Medicine, Wayne State University School of Medicine, Detroit, MI 48201, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdul Shukkur","family":"Ebrahim","sequence":"additional","affiliation":[{"name":"Lymphoma Research Laboratory, Department of Internal Medicine, Wayne State University School of Medicine, Detroit, MI 48201, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mustapha","family":"Kandouz","sequence":"additional","affiliation":[{"name":"Department of Pathology, Wayne State University School of Medicine, Detroit, MI 48201, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feras","family":"Zaiem","sequence":"additional","affiliation":[{"name":"Department of Pathology, Wayne State University School of Medicine, Detroit, MI 48201, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Raufi","sequence":"additional","affiliation":[{"name":"Lymphoma Research Laboratory, Department of Internal Medicine, Wayne State University School of Medicine, Detroit, MI 48201, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salah","family":"Ebrahim","sequence":"additional","affiliation":[{"name":"Department of Pathology, Wayne State University School of Medicine, Detroit, MI 48201, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anwar","family":"Mohamed","sequence":"additional","affiliation":[{"name":"Department of Pathology, Wayne State University School of Medicine, Detroit, MI 48201, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nada","family":"Emara","sequence":"additional","affiliation":[{"name":"Lymphoma Research Laboratory, Department of Internal Medicine, Wayne State University School of Medicine, Detroit, MI 48201, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali M.","family":"Gabali","sequence":"additional","affiliation":[{"name":"Department of Pathology, Wayne State University School of Medicine, Detroit, MI 48201, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"7892","published-online":{"date-parts":[[2020,1,14]]},"reference":[{"key":"1","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21442","article-title":"Cancer Statistics, 2018","volume":"68","author":"Jemal","year":"2018","journal-title":"CA Cancer J Clin"},{"key":"2","doi-asserted-by":"publisher","first-page":"5019","DOI":"10.1182\/blood-2011-01-293050","article-title":"The 2008 WHO classification of lymphoid neoplasms and beyond: evolving concepts and practical applications","volume":"117","author":"Jaffe","year":"2011","journal-title":"Blood"},{"key":"3","doi-asserted-by":"publisher","first-page":"2375","DOI":"10.1182\/blood-2016-01-643569","article-title":"The 2016 revision of the World Health Organization classification of lymphoid neoplasms","volume":"127","author":"Jaffe","year":"2016","journal-title":"Blood"},{"key":"4","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1182\/asheducation-2011.1.506","article-title":"Aggressive B-cell lymphomas: a review of new and old entities in the WHO classification","volume":"2011","author":"Pittaluga","year":"2011","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"5","unstructured":"National Guideline Alliance (UK). Non-Hodgkin's Lymphoma: Diagnosis and Management. London: National Institute for Health and Care Excellence (UK); 2016. (NICE Guideline, No. 52.) Available from: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK374283."},{"key":"6","doi-asserted-by":"publisher","first-page":"3048","DOI":"10.1200\/JCO.2013.53.5229","article-title":"Role of imaging in the staging and response assessment of lymphoma: consensus of the International Conference on Malignant Lymphomas Imaging Working Group","volume":"32","author":"O'Doherty","year":"2014","journal-title":"J Clin Oncol"},{"key":"7","doi-asserted-by":"publisher","first-page":"3059","DOI":"10.1200\/JCO.2013.54.8800","article-title":"Recommendations for initial evaluation, staging, and response assessment of Hodgkin and non-Hodgkin lymphoma: the Lugano classification","volume":"32","author":"Lister","year":"2014","journal-title":"J Clin Oncol"},{"key":"8","doi-asserted-by":"publisher","first-page":"e2017010","DOI":"10.4084\/mjhid.2017.010","article-title":"Is There a Role for Minimal Residual Disease Monitoring in Follicular Lymphoma in the Chemo-Immunotherapy Era?","volume":"9","author":"Rambaldi","year":"2017","journal-title":"Mediterr J Hematol Infect Dis"},{"key":"9","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1182\/asheducation-2016.1.437","article-title":"Minimal residual disease in mantle cell lymphoma: insights into biology and impact on treatment","volume":"2016","author":"Pott","year":"2016","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"10","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1016\/j.ccell.2016.11.002","article-title":"Characterization of Rare, Dormant, and Therapy-Resistant Cells in Acute Lymphoblastic Leukemia","volume":"30","author":"Parekh","year":"2016","journal-title":"Cancer Cell"},{"key":"11","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1111\/bjh.14996","article-title":"Minimal residual disease in non-Hodgkin lymphoma \u2013 current applications and future directions","volume":"180","author":"Armand","year":"2018","journal-title":"Br J Haematol"},{"key":"12","doi-asserted-by":"publisher","first-page":"3034","DOI":"10.1182\/blood.V81.11.3034.3034","article-title":"Propagation of Waldenstrom\u2019s macroglobulinemia cellsand in severe combined immune deficient mice: utility as a preclinical drug screening model","volume":"81","author":"Smith","year":"1993","journal-title":"Blood"},{"key":"13","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/0165-4608(93)90132-6","article-title":"A unique EBV-negative low-grade lymphoma line (WSU-FSCCL) exhibiting both t(14;18) and t(8;11)","volume":"70","author":"al-Katib","year":"1993","journal-title":"Cancer Genet Cytogenet"},{"key":"14","first-page":"1305","article-title":"Bryostatin 1 down-regulates mdr1 and potentiates vincristine cytotoxicity in diffuse large cell lymphoma xenografts","volume":"4","author":"Mohammad","year":"1998","journal-title":"Clin Cancer Res"},{"key":"15","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1182\/asheducation-2009.1.523","article-title":"The 2008 WHO classification of lymphomas: implications for clinical practice and translational research","volume":"2009","author":"Jaffe","year":"2009","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"16","doi-asserted-by":"publisher","first-page":"4038","DOI":"10.1158\/1078-0432.CCR-08-2808","article-title":"Superior antitumor activity of SAR3419 to rituximab in xenograft models for non-Hodgkin\u2019s lymphoma","volume":"15","author":"Zuany-Amorim","year":"2009","journal-title":"Clin Cancer Res"},{"key":"17","doi-asserted-by":"publisher","first-page":"42374","DOI":"10.18632\/oncotarget.9872","article-title":"PNT2258, a novel deoxyribonucleic acid inhibitor, induces cell cycle arrest and apoptosis via a distinct mechanism of action: a new class of drug for non-Hodgkin\u2019s lymphoma","volume":"7","author":"Al-Katib","year":"2016","journal-title":"Oncotarget"},{"key":"18","doi-asserted-by":"publisher","first-page":"1797","DOI":"10.1084\/jem.183.4.1797","article-title":"Isolation and functional properties of murine hematopoietic stem cells that are replicating","volume":"183","author":"Mulligan","year":"1996","journal-title":"J Exp Med"},{"key":"19","doi-asserted-by":"publisher","first-page":"31","DOI":"10.3109\/10428199509075300","article-title":"CD34 expression in adult acute lymphoblastic leukemia","volume":"18","author":"Impera","year":"1995","journal-title":"Leuk Lymphoma"},{"key":"20","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1111\/ijlh.12795","article-title":"Role of CD81 and CD58 in minimal residual disease detection in pediatric B lymphoblastic leukemia","volume":"40","author":"Weinberg","year":"2018","journal-title":"Int J Lab Hematol"},{"key":"21","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.bcmd.2016.05.005","article-title":"Significance of CD34\/CD123 expression in detection of minimal residual disease in B-ACUTE lymphoblastic leukemia in children","volume":"59","author":"Sattar","year":"2016","journal-title":"Blood Cells Mol Dis"},{"key":"22","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1007\/s12185-017-2206-4","article-title":"Detection of minimal residual disease in childhood B acute lymphoblastic leukemia by 4-color flowcytometry","volume":"105","author":"Shorbagy","year":"2017","journal-title":"Int J Hematol"},{"key":"23","doi-asserted-by":"publisher","first-page":"4691","DOI":"10.1182\/blood.V86.12.4691.bloodjournal86124691","article-title":"Detection of clonal CD34+19+ progenitors in bone marrow of BCL2-IgH-positive follicular lymphoma patients","volume":"86","author":"Schmitt","year":"1995","journal-title":"Blood"},{"key":"24","doi-asserted-by":"publisher","first-page":"3683","DOI":"10.1242\/jcs.037507","article-title":"Novel functions of the CD34 family","volume":"121","author":"McNagny","year":"2008","journal-title":"J Cell Sci"},{"key":"25","doi-asserted-by":"publisher","first-page":"9001","DOI":"10.1074\/jbc.275.12.9001","article-title":"Identification of endoglycan, a member of the CD34\/podocalyxin family of sialomucins","volume":"275","author":"Rosen","year":"2000","journal-title":"J Biol Chem"},{"key":"26","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1111\/j.1365-2141.2004.04840.x","article-title":"Podocalyxin in human haematopoietic cells","volume":"124","author":"Miettinen","year":"2004","journal-title":"Br J Haematol"},{"key":"27","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1385\/IR:34:1:13","article-title":"Beyond mere markers: functions for CD34 family of sialomucins in hematopoiesis","volume":"34","author":"McNagny","year":"2006","journal-title":"Immunol Res"},{"key":"28","doi-asserted-by":"publisher","first-page":"6398","DOI":"10.1158\/1078-0432.CCR-14-0407","article-title":"Minimal residual disease after conventional treatment significantly impacts on progression-free survival of patients with follicular lymphoma: the FIL FOLL05 trial","volume":"20","author":"Mantoan","year":"2014","journal-title":"Clin Cancer Res"},{"key":"29","doi-asserted-by":"publisher","first-page":"336","DOI":"10.3324\/haematol.2015.134957","article-title":"Minimal residual disease monitoring by 8-color flow cytometry in mantle cell lymphoma: an EU-MCL and LYSA study","volume":"101","author":"Jardin","year":"2016","journal-title":"Haematologica"},{"key":"30","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.jim.2014.03.004","article-title":"Common consensus LNA probe for quantitative PCR assays in cancer: vehicles for minimal residual disease detection in t(11;14) and t(14;18) positive malignant lymphomas","volume":"406","author":"Nyvold","year":"2014","journal-title":"J Immunol Methods"},{"key":"31","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1016\/j.jmoldx.2015.05.007","article-title":"Minimal Residual Disease Detection by Droplet Digital PCR in Multiple Myeloma, Mantle Cell Lymphoma, and Follicular Lymphoma: A Comparison with Real-Time PCR","volume":"17","author":"Omed\u00e8","year":"2015","journal-title":"J Mol Diagn"},{"key":"32","doi-asserted-by":"publisher","first-page":"288","DOI":"10.3390\/jcm7090288","article-title":"New Molecular Technologies for Minimal Residual Disease Evaluation in B-Cell lymphoid Malignancies","volume":"7","author":"Ferrero","year":"2018","journal-title":"J Clin Med"},{"key":"33","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1038\/ng.2856","article-title":"Integrated genomic analysis identifies recrurrent mutations and evolution patterns driving the initiation and progression of follicular lymphoma","volume":"46","author":"Marzec","year":"2014","journal-title":"Nat Genet"},{"key":"34","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1111\/j.1349-7006.2009.01452.x","article-title":"Diversity of genome profiles in malignant lymphoma","volume":"101","author":"Nakagawa","year":"2010","journal-title":"Cancer Sci"},{"key":"35","doi-asserted-by":"publisher","first-page":"14228","DOI":"10.1073\/pnas.0400067101","article-title":"A distinct \u201cside population\u201d of cells with high drug efflux capacity in human tumor cells","volume":"101","author":"Brenner","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"key":"36","doi-asserted-by":"publisher","first-page":"3882","DOI":"10.1182\/blood.V97.12.3882","article-title":"Hoechst 33342 efflux identifies a subpopulation of cytogenetically normal CD34(+)CD38(-) progenitor cells from patients with acute myeloid leukemia","volume":"97","author":"Hogge","year":"2001","journal-title":"Blood"},{"key":"37","doi-asserted-by":"publisher","first-page":"1532","DOI":"10.1111\/j.1582-4934.2009.00865.x","article-title":"Side population of a murine mantle cell lymphoma model contains tumour-initiating cells responsible for lymphoma maintenance and dissemination","volume":"14","author":"Medeiros","year":"2010","journal-title":"J Cell Mol Med"},{"key":"38","doi-asserted-by":"publisher","first-page":"870","DOI":"10.3109\/10428191003713968","article-title":"Antigen-specific cytotoxic T lymphocytes can target chemoresistant side-population tumor cells in Hodgkin lymphoma","volume":"51","author":"Foster","year":"2010","journal-title":"Leuk Lymphoma"},{"key":"39","doi-asserted-by":"publisher","first-page":"2490","DOI":"10.1111\/j.1349-7006.2010.01693.x","article-title":"The side population, as a precursor of Hodgkin and Reed-Sternberg cells and a target for nuclear factor-kappaB inhibitors in Hodgkin\u2019s lymphoma","volume":"101","author":"Horie","year":"2010","journal-title":"Cancer Sci"},{"key":"40","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.exphem.2009.11.008","article-title":"A subpopulation of malignant CD34+CD138+B7-H1+ plasma cells is present in multiple myeloma patients","volume":"38","author":"Quesnel","year":"2010","journal-title":"Exp Hematol"},{"key":"41","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1111\/j.1365-2141.2006.06398.x","article-title":"Transmission of a follicular lymphoma by allogeneic bone marrow transplantation\u2013evidence to support the existence of lymphoma progenitor cells","volume":"136","author":"Lai","year":"2007","journal-title":"Br J Haematol"},{"key":"42","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1001\/jamaoncol.2016.0004","article-title":"Durable responses with maintenance dose-sparing regimens of Romidepsin in cutaneous T-cell lymphoma","volume":"2","author":"Guitart","year":"2016","journal-title":"JAMA Oncol"}],"container-title":["Oncotarget"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.27415","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,6]],"date-time":"2020-06-06T15:38:30Z","timestamp":1591457910000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.27415"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1,14]]},"references-count":42,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,1,14]]}},"alternative-id":["27415","32010428"],"URL":"https:\/\/doi.org\/10.18632\/oncotarget.27415","relation":{},"ISSN":["1949-2553"],"issn-type":[{"value":"1949-2553","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,1,14]]}}}